Article info
PDFHow to understand it
NICE and neurology
- D Chadwick Emeritus Professor of Neurology, University of Liverpool, Walton Centre, Liverpool L9 7LJ, UK; d.w.chadwick{at}liv.ac.uk
Citation
NICE and neurology
Publication history
- First published September 17, 2009.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd.
Other content recommended for you
- Research ethics and evidence based medicine
- The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process
- NICE is dead; long live NICE
- NICE’s new methods: putting innovation first, but at what cost?
- NICE: faster access to modern treatments? Analysis of guidance on health technologies
- The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis
- The unintended consequences of NICE
- Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
- National Institute for Clinical Excellence and its value judgments
- Wickedness or folly? The ethics of NICE’s decisions